Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
09/2003
09/04/2003WO2002097395A3 P-cadherin as a target for anti-cancer therapy
09/04/2003WO2002097073A3 Regulation of human phospholipase c delta-like enzyme
09/04/2003WO2002095054A3 Method of determining protein interaction inhibitors
09/04/2003WO2002083886A3 Means and method for the preparation of transgenic plants resistant to viral infections
09/04/2003WO2002079465A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
09/04/2003WO2002079424A3 TRANSGENIC MICE CONTAINING β3GALT2 GENE DISRUPTIONS
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002072804A3 Novel genes for conditional cell ablation
09/04/2003WO2002053775A3 Identification of genetic determinants of polymorphic cyp3a5 expression
09/04/2003WO2002052020A3 Regulation of human carboxypeptidase a
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002046209A3 Haplotypes of the cyp3a5 gene
09/04/2003WO2002044331A3 Dap-kinase and hoxa9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer
09/04/2003WO2002038746A3 Novel thermostable alkaliphilic xylanase
09/04/2003WO2002034923A9 Monocotyledon plant cells and plants which synthesise modified starch
09/04/2003WO2002033109A3 Fermentation method for production of heterologous gene products in lactic acid bacteria
09/04/2003WO2002024893A3 CHARACTERIZATION OF THE GSK-3β PROTEIN AND METHODS OF USE THEREOF
09/04/2003WO2002024889A3 Optimized cardiac contraction through differential phosphorylation of myosin
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030167544 Low lipoxygenase 1 barley
09/04/2003US20030167538 Genetic engineered plants; corn, wheat, rice
09/04/2003US20030167536 Plant adpglucose pyroghophatase, method for the production thereof, its use in the production of assay devices and for obtaining transgenic plants
09/04/2003US20030167535 Comprises farnesyl transferases
09/04/2003US20030167534 Method of producing heteromultimeric mammalian proteins in plants
09/04/2003US20030167532 OAR polynucleotides, polypeptides and their use in PHA production in plants
09/04/2003US20030167530 Polpeptides have pyrimidine dimer excision activity; for creating male sterile plants or seedless fruits
09/04/2003US20030167529 Plants synthesizing a modified starch, a process for the generation of the plants, their use, and the modified starch
09/04/2003US20030167528 Lyases; replicating libraries; transgenic plants
09/04/2003US20030167527 Transgenic plant; genetic engineering
09/04/2003US20030167525 Desaturase genes and uses thereof
09/04/2003US20030167523 Adjust oil concentration in seeds; genetic engineering
09/04/2003US20030167516 Calcium dependent protein kinase polypeptides as regulators of plant disease resistance
09/04/2003US20030167514 For screening/conferring tolerance in plants
09/04/2003US20030167513 Selection and use of isopropylmalate synthase (IPMS) mutants desensitized in L-leucine negative feedback control
09/04/2003US20030167511 Production of p-hydroxybenzoic acid
09/04/2003US20030167510 Hydroperoxide lyase gene from maize and methods of use
09/04/2003US20030167509 Comprises imidazoleglycerol-phosphate dehydratase activity; herbicides; fungicides
09/04/2003US20030167508 Novel plant tryptophan synthase beta subunit
09/04/2003US20030167503 Plant genes encoding pantothenate synthetase
09/04/2003US20030167501 Antibiotic resistant protein; insertion into plants
09/04/2003US20030167499 Transgenic mice having decreased fat accumulation; homologous recombination; dietetics
09/04/2003US20030167484 Mutant genes; transgenic animals; insertion of stem cell
09/04/2003US20030167483 Analyzing; genetic engineering; transgenic animals, plants
09/04/2003US20030167481 Methods for amplifying gentic material and uses thereof
09/04/2003US20030167477 Fusion proteins incorporating lysozyme
09/04/2003US20030167474 Superoxide dismutase reduced animal model; Parkinson's disease, sepsis, amyotropic lateral sclerosis; prevent free radical damage
09/04/2003US20030166919 Plant starch compostion
09/04/2003US20030166905 Mutant luciferases
09/04/2003US20030166902 Hybrid; process control; genetic engineering
09/04/2003US20030166900 Isolated nucleic acids; analgesics, antiinflammatory agents
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166897 Diagnosis, therapy cancer; transgenic animal
09/04/2003US20030166896 Polynucleotide containing phosphoramidite group
09/04/2003US20030166889 Novel human kinases and polynucleotides encoding the same
09/04/2003US20030166888 Hybrid nucleic acid
09/04/2003US20030166886 Candida albicans proteins associated with virulence and hyphal formation and uses thereof
09/04/2003US20030166855 Lipoxygenase polynucleotides and methods of use
09/04/2003US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound
09/04/2003US20030166848 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin
09/04/2003US20030166843 Scalable three dimensional set of points is derived from structure coordinates of at least the backbone atoms of amino acids representing FAD binding site and/or an NADPH binding site of an staphylococcus thioredoxin reductase molcule
09/04/2003US20030166839 Controlling gene expression
09/04/2003US20030166623 Novel steroid hormone receptor interacting protein kinase
09/04/2003US20030166596 DNA which encodes trehalase and uses thereof
09/04/2003US20030166595 Novel deoxygenases catalyzing cleavage of beta-carotene
09/04/2003US20030166592 For treatment of metabolic disorders (diabetes, obesity)
09/04/2003US20030166587 Compounds and methods for modulating activation of NF-kB
09/04/2003US20030166580 Substituted amino carboxamides for the treatment of alzheimer's disease
09/04/2003US20030166579 Thrombin inhibitors comprising an aminoisoquinoline group
09/04/2003US20030166576 Urokinase inhibitors
09/04/2003US20030166548 Synthetic milittin and related peptides derived from the sequence of human phospholipase A2-activating protein (PLAP), free from the contaminating phospholipase A2 (PLA2) and/or present when the peptides are purified from natural sources,
09/04/2003US20030166534 Suppressing a class II MHC-restricted immune response in a mammal, or in mammalian cells, are described. The methods depend upon inhibiting invariant chain proteolysis by cathepsin S from class II MHC/invariant chain complexes,
09/04/2003US20030166514 Pharmaceutical composition comprising (a) the cyclic peptide compound of Formula 1 or Formula 2 as antigrowth agents or anticancer agents
09/04/2003US20030166288 Altering Ku80 levels in plants; recobinant expression cassettes
09/04/2003US20030166285 Methods and compositions for genetically modifying primate bone marrow cells
09/04/2003US20030166283 Drug screening a modulator as antitumor agents, antiproliferative agents, as promoter providing neuronal cell growth, wound healing, and cerebral injury healing; genetic engineering, receptor binding assay, gene expression
09/04/2003US20030166270 Cell culturing with a mutant modified cyclin dependent kinase protein, screening cancer-causing agents
09/04/2003US20030166255 Culturing a host cell for expressing a first recombinant protein isoprenoid synthase and a second recombinant protein cytochromes, for transforming a disease resistance plants; genetic engineering
09/04/2003US20030166250 Cerebrosides/gangliosides; derived from Pseudomonas or Shewanella
09/04/2003US20030166249 PEG-urate oxidase conjugates and use thereof
09/04/2003US20030166248 Proteases from gram-positive organisms
09/04/2003US20030166247 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures
09/04/2003US20030166246 Human aspartic proteases
09/04/2003US20030166244 57316 and 33338, human ubiquitin carboxyl terminal hydrolases and uses therefor
09/04/2003US20030166243 Regulation of target protein activity through modifier proteins
09/04/2003US20030166242 25828, a novel human aminopeptidase and uses therefor
09/04/2003US20030166241 Tryptophan translases; for production of herbicides
09/04/2003US20030166238 Recombinant toxin fragments
09/04/2003US20030166236 Obtained from Trichoderma; high temperature/ph production; papermaking/bleaching
09/04/2003US20030166235 Enzyme inhibitors; immunoassay
09/04/2003US20030166233 Crystallization and structure determination of staphylococcus aureus NAD synthetase
09/04/2003US20030166227 Comprises polypeptides having exonuclease domains in plants; homologous recombination
09/04/2003US20030166226 Mixing (1a,3b,5E,7E,20R)-1,3-bis(tert-butyldimethylsiloxy)-20-(3'-cyclopropyl -3'(R,S)-hydroxy-1'-propenyl)-9,10-secopregna-5,7,10(19)-triene with lipase
09/04/2003US20030166225 Platelet activating factor acetyl hydrolase; for diagnosing asthma
09/04/2003US20030166224 18232, a novel dual specificity phosphatase and uses therefor
09/04/2003US20030166223 IL-1/TNF-alpha-activated kinase (ITAK), and methods of making and using the same
09/04/2003US20030166222 Serine/threonine kinases; fusion proteins; drug screening
09/04/2003US20030166221 Megakaryocyte tyrosine kinases; signal transduction in hematopoietic cells
09/04/2003US20030166220 Elucidate molecular mechanisms in learning and memory, the expression of mRNAs in brains of rabbits undergoing eyeblink conditioning was analyzed. Infusion of the transcription inhibitor actinomycin D (ActD) into the cerebellar nuclei
09/04/2003US20030166219 Mitogen-activated protein/extracellular signal-regulated kinases (MAP/ERK)
09/04/2003US20030166218 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
1 ... 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 ... 1416